The Life Sciences Sector businesses supply a range of medical devices, consumables, instrumentation and related services to Healthcare and Environmental end markets.


Year Ended 30 Sept

  FY 2021 FY 2020  
Revenue £180.4m £139.7m +29%
Unedrlying revenue growth +14% (4)%  
Adjusted operating margin £43.2m £30.4m +42%
Free cash flow 23.9% 21.8% +210bps

FY 2021 highlights

  • Strong underlying growth of 14%.
  • Build-out of European footprint provides diversification and growth opportunities.
  • Very positive performance from Scandinavian acquisitions.
  • Disciplined portfolio management: Q4 disposal of a1-CBISS.

Our businesses

Principal segments1